- Home
- RVMD vs THG Comparison
RVMD vs THG Comparison
Compare RVMD & THG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | THG |
|---|---|---|
| Founded | 2014 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.3B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RVMD | THG |
|---|---|---|
| Price | $77.65 | $179.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 7 |
| Target Price | $77.11 | ★ $194.29 |
| AVG Volume (30 Days) | ★ 2.3M | 180.3K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | N/A | ★ 73.14 |
| EPS | N/A | ★ 17.31 |
| Revenue | N/A | ★ $6,506,900,000.00 |
| Revenue This Year | N/A | $4.23 |
| Revenue Next Year | $714.50 | $5.20 |
| P/E Ratio | ★ N/A | $10.34 |
| Revenue Growth | N/A | ★ 5.26 |
| 52 Week Low | $29.17 | $145.17 |
| 52 Week High | $79.07 | $188.18 |
Technical Indicators
Market Signals| Indicator | RVMD | THG |
|---|---|---|
| Relative Strength Index (RSI) | 79.18 | 47.05 |
| Support Level | $69.50 | $185.00 |
| Resistance Level | $78.17 | $188.18 |
| Average True Range (ATR) | 2.78 | 3.44 |
| MACD | 0.17 | -0.08 |
| Stochastic Oscillator | 90.88 | 12.07 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About THG Hanover Insurance Group Inc
The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.